Caregiver Connection | DANYELZA® (naxitamab-gqgk)

Learn from other caregivers

Connect with families who have experience with DANYELZA®

DANYELZA Caregiver Connection Logo

DANYELZA Caregiver Connection is a program designed to help caregivers of children with relapsed or refractory high-risk neuroblastoma. We aim to connect you with resources and information about treatment with DANYELZA from the perspective of someone who has been there before.

Through this program, you can engage with stories of caregivers who have been through DANYELZA treatment with their child. You can access these stories by watching videos, reading tips, attending live events, or joining the discussion on our Facebook page >

Connect with our ambassadors

Our caregiver ambassadors are parents who want to share their personal experiences with DANYELZA. They are passionate about telling their story in the hopes that it may help you along your own journey with your child.

DANYELZA Caregiver, Rachalle

Meet Rachalle

“There are no words for having community like that. Just having the support and knowing that you’re not alone, it’s huge.”

Rachalle is a mother of 2 boys and a former 5th grade science teacher. She has experience navigating relapsed high-risk neuroblastoma and DANYELZA treatment with her son, Luke. Both Rachalle and her husband leaned on their community for support throughout the treatment journey.

Watch Luke’s story>
DANYELZA Caregiver, Heather

Meet Heather

“I’m just proud to be able to help other people. That’s very rewarding. I think we could move mountains. I really do.”

Heather is a mother of 4 who is passionate about sharing her and her tight-knit family’s experiences with high-risk neuroblastoma. Her son, Michael, was introduced to DANYELZA after he did not respond to initial treatment.

Watch Michael’s story>
DANYELZA Caregiver, Spencer

Meet Spencer

“We as caregivers are our own best resources for knowledge. When we share our stories, we help each other continue to be strong for our children.”

Spencer is a father of 4 with experience in researching and advocating for treatments for high-risk neuroblastoma. When his daughter, Ava, received a relapse diagnosis, finding a treatment plan helped give him and his family hope.

Watch Ava’s story>

Connect with us live

Throughout the year, DANYELZA Caregiver Connection hosts educational events to connect you with caregivers who have experience with DANYELZA. See below for details about upcoming events and past events.

Upcoming events

November
8
7:00 PM EST

Navigating the Start of the Treatment Journey

Register Now

Past events

Advocating for your child and the DANYELZA treatment experience

WATCH NOW
DANYELZA Caregiver Connection on Laptop

Connect with us on Facebook

Facebook Logo Icon

You can stay up-to-date on the latest news about live events on our Facebook page. Additionally, you can access more tips and insights from our ambassadors as well as engage in conversation with others in the community.
Go now >

DANYELZA Caregiver Connection

DANYELZA Caregiver Connection

4 weeks 12 hours ago

February 28 is Rare Disease Day, and it’s an opportunity to bring attention to rare childhood cancers. Share how you raise awareness below! What is

3
View on Facebook
Share
DANYELZA Caregiver Connection

DANYELZA Caregiver Connection

1 month 3 weeks ago

Neuroblastoma is a rare and devastating childhood cancer. As many as 50% to 60% of patients are diagnosed with high-risk neuroblastoma disease. Let’s come together

View on Facebook
Share

Connect via email

Email Enrollment Icon

Join our email list for the latest news about DANYELZA Caregiver Connection. Emails will include updated information about our events, the latest tips from our ambassadors, and other opportunities to connect with the community.

SIGN UP

Quick links

Watch stories from
actual DANYELZA families

Learn how to get DANYELZA
for your child

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about DANYELZA?
DANYELZA may cause serious side effects, including:

Serious infusion-related reactions. DANYELZA can cause serious infusion-related reactions that require immediate medical attention. Infusion-related reactions are common with DANYELZA. Tell your healthcare provider right away if you get any signs or symptoms during or after your DANYELZA infusion, including:

  • swelling of your face, eyes, lips, mouth, or tongue
  • itching
  • redness on your face (flushing)
  • skin rash or hives
  • trouble breathing
  • cough or wheezing
  • noisy high-pitched breathing
  • feeling faint or dizziness (low blood pressure)

WHAT IS DANYELZA?

DANYELZA is a prescription medicine used in combination with a medicine called granulocyte-macrophage colony-stimulating factor (GM-CSF) to treat children 1-year of age and older and adults with high-risk neuroblastoma in the bone or bone marrow that:

  • has come back (relapsed) or that did not respond to previous treatment (refractory), and
  • has shown a partial response, minor response, or stable disease to prior therapy.

DANYELZA is approved based on two clinical studies that looked at reducing tumor size. DANYELZA is still being studied to confirm the study results and the clinical benefit of treatment.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about DANYELZA?
DANYELZA may cause serious side effects, including:

Serious infusion-related reactions. DANYELZA can cause serious infusion-related reactions that require immediate medical attention. Infusion-related reactions are common with DANYELZA. Tell your healthcare provider right away if you get any signs or symptoms during or after your DANYELZA infusion, including:

  • swelling of your face, eyes, lips, mouth, or tongue
  • itching
  • redness on your face (flushing)
  • skin rash or hives
  • trouble breathing
  • cough or wheezing
  • noisy high-pitched breathing
  • feeling faint or dizziness (low blood pressure)

WHAT IS DANYELZA?

DANYELZA is a prescription medicine used in combination with a medicine called granulocyte-macrophage colony-stimulating factor (GM-CSF) to treat children 1-year of age and older and adults with high-risk neuroblastoma in the bone or bone marrow that:

  • has come back (relapsed) or that did not respond to previous treatment (refractory), and
  • has shown a partial response, minor response, or stable disease to prior therapy.

DANYELZA is approved based on two clinical studies that looked at reducing tumor size. DANYELZA is still being studied to confirm the study results and the clinical benefit of treatment.

Nervous system problems. Talk to your healthcare provider right away if you have new symptoms or worsening of nervous system problems, including:

  • Severe pain from nerves (neuropathic pain), including pain in the belly (abdomen), bone, neck, legs, or arms. Pain is common with DANYELZA and can be severe.
  • Inflammation of the spinal cord. Signs or symptoms may include:
    • weakness in your legs or arms
    • bladder and bowel problems
    • pain in back, legs, or stomach (abdomen)
    • numbness
    • tingling
    • burning sensation
  • Reversible Posterior Leukoencephalopathy Syndrome (RPLS – also known as Posterior Reversible Encephalopathy Syndrome - PRES). PRES is a condition that affects the brain. Your healthcare provider will monitor your blood pressure and check for any neurologic symptoms after your DANYELZA infusion. Signs or symptoms of PRES may include:
    • severe headache
    • vision changes
    • changes in mental status, such as confusion, disorientation, or decreased alertness
    • difficulty speaking
    • weakness in your arms or legs
    • seizures
  • Numbness, tingling, or burning sensation in the arms or legs.
  • Nervous system problems of the eye. Signs or symptoms may include:
    • unequal pupil size
    • blurred vision
    • trouble focusing your eyes
    • larger pupil size (dilated)
    • decreased ability to see
    • sensitivity to light
  • Problems urinating or emptying your bladder (prolonged urinary retention).

Do not receive DANYELZA if you have had a severe allergic reaction to naxitamab-gqgk (the active ingredient in DANYELZA). Ask your healthcare provider if you are not sure.

Before receiving DANYELZA, tell your healthcare provider about all your medical conditions, including if you:

  • have high blood pressure
  • are pregnant or plan to become pregnant. DANYELZA may harm your unborn baby.
    • Your healthcare provider will do a pregnancy test before you start treatment with DANYELZA.
    • Females who are able to become pregnant should use effective birth control (contraception) during treatment and for 2 months after your last dose of DANYELZA. Talk to your healthcare provider about birth control choices that may be right for you during this time.
    • Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with DANYELZA.
  • are breastfeeding or plan to breastfeed. It is not known if DANYELZA passes into your breast milk. Do not breastfeed during treatment and for 2 months after your last dose of DANYELZA.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of DANYELZA?
DANYELZA may cause serious side effects, including:

  • See “What is the most important information I should know about DANYELZA?”
  • High blood pressure (hypertension). High blood pressure is common in people who receive DANYELZA. Your blood pressure will be monitored during your DANYELZA infusion, and at least each day on Days 1 to 8 of each DANYELZA treatment cycle. Tell your healthcare provider right away if you get any signs or symptoms of high blood pressure, including:
    • headaches
    • seizures
    • nausea or vomiting
    • chest pain
    • dizziness
    • visual changes
    • shortness of breath
    • feeling that your heart is pounding or racing (palpitations)
    • nose bleeds

The most common side effects of DANYELZA include:

  • fast heart rate
  • vomiting
  • cough
  • nausea
  • decreased white blood cell, red blood cell, and platelet counts
  • diarrhea
  • decreased appetite
  • tiredness
  • skin rashes
  • decreased level of potassium, sodium, and phosphate in the blood
  • hives
  • fever
  • headache
  • injection site reaction
  • swelling of the body or only in one part of the body
  • anxiety
  • irritability
  • increased liver function blood tests
  • decreased blood sugar level
  • decreased calcium levels in the blood
  • decreased protein levels (albumin) in the blood

These are not all of the possible side effects of DANYELZA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please click for full Prescribing Information and Patient Information for DANYELZA including Boxed Warning on serious infusion-related reactions and nervous system problems, and talk to your doctor.